IT1270260B - Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi - Google Patents

Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi

Info

Publication number
IT1270260B
IT1270260B ITMI941291A ITMI941291A IT1270260B IT 1270260 B IT1270260 B IT 1270260B IT MI941291 A ITMI941291 A IT MI941291A IT MI941291 A ITMI941291 A IT MI941291A IT 1270260 B IT1270260 B IT 1270260B
Authority
IT
Italy
Prior art keywords
metallopeptidase
acid derivatives
phosphonic acid
inhibitive
activities
Prior art date
Application number
ITMI941291A
Other languages
English (en)
Inventor
Gabriele Norcini
Daniela Botta
Francesco Santangelo
Gabriele Morazzoni
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of ITMI941291A0 publication Critical patent/ITMI941291A0/it
Priority to ITMI941291A priority Critical patent/IT1270260B/it
Priority to US08/750,035 priority patent/US5739123A/en
Priority to AT95924260T priority patent/ATE169301T1/de
Priority to JP8501655A priority patent/JPH10501546A/ja
Priority to EP95924260A priority patent/EP0766687B1/en
Priority to PCT/EP1995/002343 priority patent/WO1995035302A1/en
Priority to AU28842/95A priority patent/AU2884295A/en
Priority to SI9520067A priority patent/SI9520067A/sl
Priority to DE69503904T priority patent/DE69503904T2/de
Priority to ES95924260T priority patent/ES2122646T3/es
Publication of ITMI941291A1 publication Critical patent/ITMI941291A1/it
Application granted granted Critical
Publication of IT1270260B publication Critical patent/IT1270260B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Vengono descritti composti di formula (FORMULA I) in cui R. R1, R2, m ed X hamo i significati riportati nella descrizione.I composti di formula I sono dotati di attività mista ACE - inibitrice e NEP - inibitrice e sono utili nel trattamento di disturbi cardiovascolari.
ITMI941291A 1994-06-21 1994-06-21 Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi IT1270260B (it)

Priority Applications (10)

Application Number Priority Date Filing Date Title
ITMI941291A IT1270260B (it) 1994-06-21 1994-06-21 Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi
EP95924260A EP0766687B1 (en) 1994-06-21 1995-06-16 Phosphinic acid derivatives with metallopeptidase inhibitory activity
AT95924260T ATE169301T1 (de) 1994-06-21 1995-06-16 Phosphinsaeurederivate mit metallopeptidase inhibtorischer wirkung
JP8501655A JPH10501546A (ja) 1994-06-21 1995-06-16 メタロペプチダーゼ阻害作用を有するホスフィン酸誘導体
US08/750,035 US5739123A (en) 1994-06-21 1995-06-16 Phosphinic acid derivatives with metallopeptidase inhibitory activity
PCT/EP1995/002343 WO1995035302A1 (en) 1994-06-21 1995-06-16 Phosphinic acid derivatives with metallopeptidase inhibitory activity
AU28842/95A AU2884295A (en) 1994-06-21 1995-06-16 Phosphinic acid derivatives with metallopeptidase inhibitory activity
SI9520067A SI9520067A (en) 1994-06-21 1995-06-16 Phosphinic acid derivates with metallopeptidase inhibitory activity.
DE69503904T DE69503904T2 (de) 1994-06-21 1995-06-16 Phosphinsaeurederivate mit metallopeptidase inhibtorischer wirkung
ES95924260T ES2122646T3 (es) 1994-06-21 1995-06-16 Derivados de acido fosfinico con actividad inhibidora de la metalopeptidasa.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941291A IT1270260B (it) 1994-06-21 1994-06-21 Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi

Publications (3)

Publication Number Publication Date
ITMI941291A0 ITMI941291A0 (it) 1994-06-21
ITMI941291A1 ITMI941291A1 (it) 1995-12-21
IT1270260B true IT1270260B (it) 1997-04-29

Family

ID=11369146

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI941291A IT1270260B (it) 1994-06-21 1994-06-21 Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi

Country Status (10)

Country Link
US (1) US5739123A (it)
EP (1) EP0766687B1 (it)
JP (1) JPH10501546A (it)
AT (1) ATE169301T1 (it)
AU (1) AU2884295A (it)
DE (1) DE69503904T2 (it)
ES (1) ES2122646T3 (it)
IT (1) IT1270260B (it)
SI (1) SI9520067A (it)
WO (1) WO1995035302A1 (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276710B1 (it) * 1995-06-14 1997-11-03 Zambon Spa Derivati dell'acido fosfinico ad attivita' inibitrice delle metallopeptidasi
FR2755135B1 (fr) * 1996-10-25 2002-12-27 Inst Nat Sante Rech Med Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent
FR2777780B1 (fr) 1998-04-22 2001-05-04 Inst Nat Sante Rech Med Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent
US6528499B1 (en) * 2000-04-27 2003-03-04 Georgetown University Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
EP2097111B1 (en) 2006-11-08 2015-07-15 Molecular Insight Pharmaceuticals, Inc. Heterodimers of glutamic acid
FR2934267B1 (fr) * 2008-07-23 2010-08-13 Pharmaleads Derives aminophosphiniques utiles dans le traitement de la douleur
WO2010051883A1 (de) * 2008-11-05 2010-05-14 Clariant International Ltd Verfahren zur herstellung von dialkylphosphinsäuren, -estern und -salzen mittels allylalkoholen/acroleinen und ihre verwendung
DE102008055914A1 (de) * 2008-11-05 2010-05-06 Clariant International Limited Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acroleinen und ihre Verwendung
DE102008055916A1 (de) * 2008-11-05 2010-05-06 Clariant International Limited Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Allylalkoholen und ihre Verwendung
DE102008056342A1 (de) * 2008-11-07 2010-05-12 Clariant International Limited Verfahren zur Herstellung von Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung
EP2352740B1 (de) * 2008-11-07 2014-09-24 Clariant Finance (BVI) Limited Verfahren zur herstellung von dialkylphosphinsäuren, -estern und -salzen mittels acrylsäurederivaten und ihre verwendung
DE102008056341A1 (de) * 2008-11-07 2010-05-12 Clariant International Limited Verfahren zur Herstellung von monoaminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Acrylnitrilen und ihre Verwendung
DE102008056339A1 (de) * 2008-11-07 2010-05-12 Clariant International Limited Verfahren zur Herstellung von mono-aminofunktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung
ES2446305T3 (es) 2008-11-11 2014-03-07 Clariant Finance (Bvi) Limited Procedimiento para la preparación de ácidos dialquilfosfínicos, sus sales y ésteres mono-alilfuncionalizados con compuestos alílicos y su uso
DE102008060035A1 (de) * 2008-12-02 2010-06-10 Clariant International Limited Verfahren zur Herstellung von mono-hydroxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung
DE102008060036A1 (de) * 2008-12-02 2010-06-10 Clariant International Limited Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylester einer Carbonsäure und ihre Verwendung
DE102008060535A1 (de) 2008-12-04 2010-06-10 Clariant International Limited Verfahren zur Herstellung von mono-carboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Vinylether und ihre Verwendung
WO2010065899A2 (en) 2008-12-05 2010-06-10 Molecular Insight Pharmaceuticals, Inc. Technetium-and rhenium-bis(heteroaryl)complexes and methods of use thereof
DE102008063668A1 (de) 2008-12-18 2010-07-01 Clariant International Limited Verfahren zur Herstellung von Alkylphosponsäuren, -estern und -salzen mittels Oxidation von Alkylphosphonigsäuren und ihre Verwendung
DE102008063642A1 (de) * 2008-12-18 2010-06-24 Clariant International Limited Verfahren zur Herstellung von monocarboxyfunktionalisierten Dialkylphosphinsäuren, -estern und -salzen mittels Alkylenoxiden und ihre Verwendung
CN102164931B (zh) 2008-12-18 2015-07-22 科莱恩金融(Bvi)有限公司 利用乙炔制备亚乙基二烷基次膦酸、亚乙基二烷基次膦酸酯和亚乙基二烷基次膦酸盐的方法,以及它们的用途
DE102008063627A1 (de) 2008-12-18 2010-06-24 Clariant International Limited Verfahren zur Herstellung von monohydroxyfunktionalisierten Dialkylphosphinsäuren,-estern und -salzen mittels Ethylenoxid und ihre Verwendung
DE102008064012A1 (de) 2008-12-19 2010-06-24 Clariant International Limited Halogenfreie Addukte von Alkylphosphonigsäurederivaten und diesterbildenden Olefinen, halogenfreie Verfahren zu deren Herstellung und ihre Verwendung
DE102008064003A1 (de) 2008-12-19 2010-06-24 Clariant International Limited Verfahren zur Herstellung von mono-funktionalisierten Dialkylphosphinsäuren, -estern und -salzen und ihre Verwendung
US8465725B2 (en) 2009-06-15 2013-06-18 Molecular Insight Pharmaceuticlas, Inc. Process for production of heterodimers of glutamic acid
CA2860504A1 (en) 2012-01-06 2013-07-11 Molecular Insight Pharmaceuticals Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase ix
CA2897437C (en) 2013-01-14 2021-12-14 Molecular Insight Pharmaceuticals, Inc. Triazine based radiopharmaceuticals and radioimaging agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379146A (en) * 1981-02-17 1983-04-05 Merck & Co., Inc. Substituted phosphonamides as antihypertensives
US4432972A (en) * 1981-08-03 1984-02-21 E. R. Squibb & Sons, Inc. Phosphonamidate compounds
US4396772A (en) * 1981-11-23 1983-08-02 F. R. Squibb & Sons, Inc. Phosphinylalkanoyl amino acids
DE3600365A1 (de) * 1986-01-09 1987-07-16 Hoechst Ag Neue thyroninderivate
IT1224405B (it) * 1987-12-23 1990-10-04 Simes Composti attivi sul sistema cardiovascolare
US5155100A (en) * 1991-05-01 1992-10-13 Ciba-Geigy Corporation Phosphono/biaryl substituted dipeptide derivatives
US5250522A (en) * 1992-10-09 1993-10-05 Ciba-Geigy Corporation Phosphono/biaryl substituted amino acid derivatives
JPH07503016A (ja) * 1992-01-15 1995-03-30 メルク　エンド　カンパニー　インコーポレーテッド 変形防止剤としての置換されたホスフィン酸含有ペプチジル誘導体
IT1254521B (it) * 1992-03-17 1995-09-25 Zambon Spa Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare

Also Published As

Publication number Publication date
US5739123A (en) 1998-04-14
SI9520067A (en) 1997-10-31
ES2122646T3 (es) 1998-12-16
ITMI941291A1 (it) 1995-12-21
EP0766687A1 (en) 1997-04-09
JPH10501546A (ja) 1998-02-10
DE69503904D1 (de) 1998-09-10
AU2884295A (en) 1996-01-15
ITMI941291A0 (it) 1994-06-21
DE69503904T2 (de) 1999-04-22
EP0766687B1 (en) 1998-08-05
ATE169301T1 (de) 1998-08-15
WO1995035302A1 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
IT1270260B (it) Derivati dell'acido fosfonico ad attivita' inibitrice delle metallopeptidasi
BG103413A (en) Derivatives of sulphinic acid, their production and application
IT1254915B (it) Derivati di adenosina ad attivita' a2 agonista
BG103964A (en) SUBSTITUTED PYRAZOLS AS p38 KINASE INHIBITORS
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
DE59409880D1 (de) Methylphosphonsäureester, verfahren zu deren herstellung und deren verwendung
DE59807405D1 (de) Acylsulfamoylbenzoesäureamide, diese enthaltende nutzpflanzenschützende mittel und verfahren zu ihrer herstellung
PT1023267E (pt) Compostos de piridilo e composicoes farmaceuticas que os contem
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
TR199800608A2 (en) Propanolamin t�revleri, bunlar�n �retim usul�.
BG104726A (en) Novel derivatives of the dihydroxyhexanoic acid
MY131693A (en) Arylacetic acid derivatives
MX9709910A (es) Compuestos que contienen arginina e imitaciones de arginina, su uso y composiciones que los contienen.
MX9700807A (es) Derivados de 3-azabiciclo (3.2.0)heptano n-sustituidos utiles como neurolepticos.
IL141325A0 (en) Tan-1057 derivatives
BG102553A (en) Thiol derivatives having metallopeptidase inhibitor activity
DE69803383D1 (de) Selektive inhibitoren des faktors x, eine azepinonstruktur enthaltend
SE9604582D0 (sv) Novel compounds
IT1270261B (it) Derivati peptidici ad attivita' inibitrice delle metallopeptidasi
ITMI931723A1 (it) Derivati della beta-mercapto-propanammide utili nel trattamento delle malattie cardiovascolari
ITMI950132A1 (it) Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
ITMI931722A1 (it) Derivati della propanammide n-eteroaril sostituiti utili nel trattamento delle malattie cardiovascolari
ZA983231B (en) Substituted benzyloxyimino compounds.
IT1255471B (it) Derivati di catecolammine,processo per la loro preparazione e composizioni farmaceutiche che li contengono
IL141009A0 (en) N-substituted azabicycloheptane derivatives, production and use thereof

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970825